Eterna Therapeutics Stock (NASDAQ: ERNA) stock price, news, charts, stock research, profile.
Open | $1.34 |
Close | $1.28 |
Volume / Avg. | 12.08K / 8.51K |
Day Range | $1.27 - $1.37 |
52 Wk Range | 0.84 - 2.63 |
Market Cap | $7.47M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 23 |
Short Interest | 0.81% |
Days to Cover | 12.53 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Eterna Therapeutics (NASDAQ:ERNA) through any online brokerage.
Other companies in Eterna Therapeutics’s space includes: Alzamend Neuro (NASDAQ:ALZN), Virios Therapeutics (NASDAQ:VIRI), Coeptis Therapeutics (NASDAQ:COEP), NuCana (NASDAQ:NCNA) and ABVC BioPharma (NASDAQ:ABVC).
There is no analysis for Eterna Therapeutics to provide a consensus price target.
The stock price for Eterna Therapeutics (NASDAQ: ERNA) is $1.38 last updated September 19, 2024 at 9:07 AM EDT.
There are no upcoming dividends for Eterna Therapeutics.
Eterna Therapeutics’s Q3 earnings are confirmed for Monday, November 11, 2024.
There is no upcoming split for Eterna Therapeutics.
Eterna Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.